Latest stories on APRE
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
Aprea Therapeutics Expands Global IP for Precision Oncology
TipRanks63 · neutralproduct/pr
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K50 · neutralgeneral
Aprea Therapeutics provides update on existing patent portfolio
The Fly50 · neutralgeneral
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
Business Insider63 · neutralproduct/pr
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
GlobeNewswire63 · neutralproduct/pr
Aprea Therapeutics records second consecutive surge, jumping another 22%
Seeking Alpha73 · bullishearnings
Aprea Therapeutics reports Q2 EPS (7c), consensus (22c)
The Fly28 · bearishearnings
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K50 · neutralgeneral
Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16
Seeking Alpha63 · neutralearnings
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
GlobeNewswire56 · neutralgeneral
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
Business Insider56 · neutralgeneral
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K34 · bearishgeneral
Aprea Therapeutics, Inc. (APRE) files 8-K
SEC 8-K50 · neutralgeneral